Horizon Pharma plc Business Finance Contracts & Agreements
72 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Credit Agreements (1)
- Escrow Agreements (1)
- Exchange Agreements (1)
- Guaranty Agreements (1)
- Indenture Agreements (18)
- Investor Rights Agreements (2)
- Joinder Agreements (1)
- Loan Agreements (8)
- Note Agreements (1)
- Purchase Agreements (4)
- Release Agreements (3)
- Share Agreements (2)
- Stock Agreements (6)
- Underwriting Agreements (7)
- Warrant Agreements (14)
- Release and Waiver of Claims of Barry Moze, dated as of January 10, 2022 (Filed With SEC on March 1, 2022)
- Release and Waiver of Claims of Brian Beeler, dated as of January 6, 2022 (Filed With SEC on March 1, 2022)
- Horizon Therapeutics Public Limited Company 2014 Non-Employee Equity Plan, as amended, and Form of Option Agreement, Form of Stock Option Grant Notice, Forms of Restricted Stock... (Filed With SEC on November 3, 2021)
- Third Supplemental Indenture, dated March 15, 2021, by and between Viela Bio, Inc. and U.S. Bank National Association (Filed With SEC on May 5, 2021)
- Incremental Amendment and Lender Joinder Agreement, dated August 17, 2020, by and among JP Morgan Chase Bank, N.A., as an incremental revolving lender and as an issuing bank,... (Filed With SEC on November 2, 2020)
- Underwriting Agreement, dated August 6, 2020, by and among Horizon Therapeutics Public Limited Company and the several underwriters named therein (Filed With SEC on August 10, 2020)
- Second Supplemental Indenture, dated April 23, 2020, by and among Horizon Properties Holding LLC, Curzion Pharmaceuticals, Inc. and U.S. Bank National Association (Filed With SEC on May 6, 2020)
- First Supplemental Indenture, dated November 19, 2019, by and between HZNP Finance Limited and U.S. Bank National Association (Filed With SEC on May 6, 2020)
- Release and Waiver of Claims of Robert F. Carey, dated as of September 18, 2019 (Filed With SEC on November 6, 2019)
- Indenture dated as of July 16, 2019 by and between Horizon Pharma USA, Inc., the guarantors party thereto and U.S. Bank National Association, as trustee (Filed With SEC on July 16, 2019)
- Horizon Therapeutics Public Limited Company 2014 Non-Employee Equity Plan, as amended, and Form of Option Agreement, Form of Stock Option Grant Notice, Forms of Restricted Stock... (Filed With SEC on May 8, 2019)
- Underwriting Agreement, dated March 6, 2019, by and among Horizon Pharma Public Limited Company and the several underwriters named therein (Filed With SEC on March 7, 2019)
- Seventh Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association (Filed With SEC on February 27, 2019)
- Third Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association (Filed With SEC on February 27, 2019)
- Sixth Supplemental Indenture, dated October 31, 2018, by and between Horizon Pharma USA, Inc. and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Fifth Supplemental Indenture, dated October 19, 2018, by and between Horizon Pharma Services LLC and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Fourth Supplemental Indenture, dated October 23, 2017, by and between Horizon Pharma Tepro, Inc. and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Third Supplemental Indenture, dated October 25, 2016, by and among Horizon Pharmaceutical LLC, Horizon Orphan LLC and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Second Supplemental Indenture, dated May 10, 2016, by and between Horizon Pharma Rheumatology LLC and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Second Supplemental Indenture, dated October 19, 2018, by and between Horizon Pharma Services LLC and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- First Supplemental Indenture, dated October 23, 2017, by and between Horizon Pharma Tepro, Inc. and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- HORIZON PHARMA, INC. and HORIZONPHARMA USA, INC. 8.750% SENIOR NOTES DUE 2024 INDENTURE Dated as of October 25, 2016 U.S. BANKNATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS (Filed With SEC on October 25, 2016)
- DATED 18 SEPTEMBER 2015 BETWEEN HORIZON PHARMAPUBLIC LIMITED COMPANY AND GOODBODY TRUSTEES LIMITED HORIZON PHARMA PUBLIC LIMITED COMPANY DIRECTOR SHARE CLOG PROGRAM (Filed With SEC on August 8, 2016)
- DATED 18 SEPTEMBER 2015 BETWEEN HORIZON PHARMA PUBLIC LIMITED COMPANY AND GOODBODY TRUSTEES LIMITED HORIZON PHARMA PUBLIC LIMITED COMPANY DIRECTOR SHARE CLOG PROGRAM (Filed With SEC on November 6, 2015)
- FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on May 11, 2015)
- CREDIT AGREEMENT dated as of May 7, 2015 among HORIZON PHARMA, INC., as Borrower, HORIZON PHARMAPUBLIC LIMITED COMPANY, as Irish Holdco and a Guarantor, THE SUBSIDIARY GUARANTORS... (Filed With SEC on May 11, 2015)
- HORIZON PHARMA FINANCING INC. 6.625% SENIOR NOTES DUE 2023 INDENTURE Dated as of April 29, 2015 U.S. BANKNATIONAL ASSOCIATION, Trustee TABLE OF CONTENTS (Filed With SEC on April 29, 2015)
- HORIZON PHARMA PUBLIC LIMITED COMPANY 15,350,000 ORDINARY SHARES, NOMINAL VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on April 16, 2015)
- HORIZONPHARMA INVESTMENT LIMITED, as Issuer HORIZON PHARMA PUBLIC LIMITED COMPANY, as Guarantor AND U.S. BANK NATIONALASSOCIATION, as Trustee Indenture Dated as ofMarch 13, 2015... (Filed With SEC on March 13, 2015)
- ASSIGNMENTAND OPTION AGREEMENT BY AND BETWEEN INTERMUNE PHARMACEUTICALS, INC. AND CONNETICSCORPORATION JUNE 23, 2000 (SUPERSEDING AND REPLACING THE AMENDED AND RESTATED EXCLUSIVE... (Filed With SEC on February 27, 2015)
- CONSENT TO ASSIGNMENT AGREEMENT BETWEEN CONNETICS AND INTERMUNE PHARMACEUTICALS, INC. JUNE 23, 2000 (Filed With SEC on February 27, 2015)
- AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on February 27, 2015)
- ASSET PURCHASE AGREEMENT (Filed With SEC on February 27, 2015)
- HORIZON PHARMA PUBLIC LIMITED COMPANY ORDINARY SHARES, NOMINAL VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on November 14, 2014)
- TEMPORARY ESCROW AGREEMENT (Filed With SEC on September 19, 2014)
- HORIZON PHARMA, INC., HORIZONPHARMA PUBLIC LIMITED COMPANY AND U.S. BANK NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTALINDENTURE Dated as of September 19, 2014 5.00%... (Filed With SEC on September 19, 2014)
- ASSET PURCHASE AGREEMENT By and between AstraZeneca AB and Horizon Pharma USA, Inc. Dated as of November 18, 2013 TABLE OF CONTENTS (Filed With SEC on March 13, 2014)
- HORIZON PHARMA, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 22, 2013 5.00% Convertible Senior Notes due 2018 TABLE OF CONTENTS (Filed With SEC on November 25, 2013)
- 21,425,000 Units Each Unit Consisting of One Share of Common Stock ($0.0001 par value per Share) And A Warrant to Purchase 0.50 of a Share of Common Stock HORIZON PHARMA, INC.... (Filed With SEC on September 20, 2012)
- HORIZON PHARMA, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 20, 2012)
